Transaction expected to facilitate enhanced focus on Xtant’s core businesses Total consideration of approximately $19.2 million allows Xtant to reduce outstanding debt and improve liquidity BELGRADE, Mont. , July 8, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc.
888.886.9354
cs@xtantmedical.com
664 Cruiser Lane
Belgrade MT, 59714